Anteris Technologies Global (AVR) Asset Utilization Ratio (2025 - 2026)
Anteris Technologies Global's (AVR) quarterly Asset Utilization Ratio came in at 0.01 in Q2 2026, down 84.27% year-over-year from 0.05 in Q2 2025, and down 32.16% quarter-over-quarter from 0.01 in Q1 2026.
Powered by 
Analysis
Anteris Technologies Global (AVR) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Asset Utilization Ratio for 2 consecutive years, with 0.01 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio fell 84.27% year-over-year to 0.01 in Q2 2026; TTM through Jun 2026 was 0.01, a 84.27% decrease from a year earlier, with the FY2025 full-year figure at 0.04, changed N/A from the prior year.
- Asset Utilization Ratio was 0.01 for Q2 2026 at Anteris Technologies Global, down from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.09 in Q4 2025 and troughed at 0.01 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 0.42 |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 0.54 |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 0.40 |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 0.55 |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 0.47 |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 0.48 |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 0.34 |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 0.76 |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 0.56 |
| 10 | Anteris Technologies Global | 816.49 Mn | 816.49 Mn | 776,000.00 | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.04 |